Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty


The purpose of this study is to compare the effect of single adductor-canal-block versus single femoral nerve block on the recovery after total knee arthroplasty.

Full Title of Study: “Comparison of the Effect of Single Adductor-canal-block and Peri-articular Infiltration on the Outcome After Unilateral Total Knee Arthroplasty”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Investigator, Outcomes Assessor)
  • Study Primary Completion Date: December 2017

Detailed Description

The aim of this study is to assess the effect of different analgesic effects on the outcome of patients undergoing total knee arthroplasty. Patients who will have primary unilateral total knee replacement between September 2016 to June 2018 at Peking Union Medical College Hospital and meet the inclusion criteria will be included. They are randomized into two groups. The total knee arthroplasty is performed by one surgeon and adductor-canal block is performed by one anesthesiologist who is not responsible for follow-up. Patients on both groups will have intravenous patient control analgesia with 1 mg morphine/bolus. One residency is responsible for the follow-up.


  • Drug: single adductor-canal-block
    • Single adductor-canal-block is performed before the surgery. A 12Hz linear ultrasound transducer is placed on the medial part of the thigh with the leg slightly externally rotated. The femoral artery was identified in short axis in the adductor canal, underneath the sartorius muscle. After skin disinfection , an 18-gauge needle (B.Braun Medical, Melsungen, Germany) is inserted in-plane from the lateral side of the transducer. The needle tip was placed underneath the sartorius muscle, just lateral to the artery and saphenous nerve, using 2-3 ml of saline to ensure correct placement. 25 ml of 0.35% ropivacaine is slowly injected with repeated aspiration.
  • Drug: periarticular infiltration
    • The periarticular infiltration of multimodal agents will involve the preparation of a mixture of 100 ml solution. The mixture contains 30ml (300mg) ropivacaine, 0.5ml (5 mg) morphine, 2 ml (50 mg) flurbiprofen and 0.5 ml of 1:1000 epinephrine, and then is diluted with 0.9% normal saline to a total volume of 100ml. 50 ml of mixture will be injected into the anterior, medial and lateral soft tissues after the implantation of the joint prostheses. The remaining 50 ml of mixture will be injected into intraarticular space after the closure of articular capsule.

Arms, Groups and Cohorts

  • Experimental: single adductor-canal-block
    • Patients in this group will receive ultrasound guided single adductor-canal- block with 0.35% ropivacaine 25ml.
  • Experimental: periarticular infiltration
    • patients in this group will receive periarticular infiltration of local anesthetic.

Clinical Trial Outcome Measures

Primary Measures

  • the time required for functional recovery
    • Time Frame: from the date of the surgery to the time when the patients meet the criteria of functional recovery. The earliest day on which the patient achieves the criteria of functional recovery will be recorded and the average time is 7 days after surgery.
    • Patients are evaluated postoperatively to determine whether the patients have meet the criteria of functional recovery.The criteria of functional recovery are as followings: walking distance more than 70m with crutch, getting up or standing up independently and visual analog score less than 5 both in rest and after movement. Before discharge, patients are assessed every morning. After discharge, patients are followed up by phone every two days.

Secondary Measures

  • postoperative WOMAC scales
    • Time Frame: pre-operative, three months,six months and one year afer the surgery
    • We compare the WOMAC scales of two groups before, three months, six months, and one year after the surgery.
  • Postoperative complications
    • Time Frame: daily after the surgery until discharge from hospital, expected average up to 5 days after the surgery
    • Any complication, including nause and vomiting, deep vein thrombosis, pulmonary embolism, pulmonary infection, urinary tract infection,cardiovascular event and falls are recorded during inhospital stay.
  • postoperative VAS scale
    • Time Frame: pre-operative, 6h postoperative, 24h postoperative, 48h postoperative, one month postoperative, three-month postoperative, one year postoperative
    • Pain at rest and while moving are evaluated by a visual analog scale preoperative, 6h, 24h, 48h, 1month, 3 months and 1 year after the surgery.
  • postoperative morphine consumption
    • Time Frame: 6h, 24h, 48h after the surgery
    • Consumptions of morphine are recorded at 6h, 24h, 48h after the surgery.
  • postoperative SF-36 score
    • Time Frame: pre-operative, three months,six months and one year afer the surgery
    • We compare the SF-36 score of two groups before, three months,six months and one year after the surgery.

Participating in This Clinical Trial

Inclusion Criteria

  • osteoarthritis – unilateral total knee arthroplasty – ASA grade I – II – normal cognitive function. Exclusion Criteria:

  • patients refuse – BMI > 35 – diagnosis other than osteoarthritis – allergy to the drugs used or contraindication to the intervention

Gender Eligibility: All

Minimum Age: 45 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Peking Union Medical College Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Yuguang Huang, Dr, Study Chair, Peking Union Medical College Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.